Recently, the Chengdu Health Commission released the evaluation results of clinical key specialties in Chengdu for the year 2025. Dr. Yang Fan, the chairperson of the Western Precision Medicine and Molecular Pathology Committee of Chengdu High-tech Medical Association, and the Department of Pathology of Chengdu Fifth People's Hospital, with its outstanding disciplinary advantages, superb diagnostic techniques and complete management system, successfully achieved the title of "Clinical Key Specialty in Chengdu". This is not only an authoritative recognition of the comprehensive strength of the department, but also marks a new height in the construction of the hospital's pathological diagnosis discipline.

Pathological diagnosis is the "gold standard" for disease confirmation and is the core supporting link in clinical diagnosis and treatment. For a long time, the Pathology Department of Chengdu Fifth People's Hospital has been guided by the quality policy of "fairness, accuracy, timeliness, and satisfaction", steadily promoting the construction of the discipline's core content, and continuously consolidating the foundation for development. The department has built a team with a reasonable hierarchical structure and excellent professional qualities, covering multiple fields such as histopathology, cytopathology, immunohistochemistry, and molecular pathology. All members possess a solid theoretical foundation and rich clinical practical experience, providing a solid talent guarantee for high-quality diagnostic work.

In terms of technical capacity building, the department closely follows the latest trends in medical science and actively introduces and standardizes the implementation of a number of advanced diagnostic technologies. Currently, it routinely conducts characteristic projects such as in-surgery rapid frozen pathological diagnosis, immunohistochemical staining, special staining, fluorescence in situ hybridization (FISH), and tumor gene detection, which can provide key references for the precise classification, prognosis assessment, and treatment plan formulation of various diseases such as tumors, infectious diseases, and autoimmune diseases. At the same time, the department is the first laboratory in Sichuan Province to obtain ISO15189 certification and has established a full-process quality control system. From specimen receipt, slide preparation and staining to the issuance of diagnosis reports, every step strictly follows national standards and regulations to ensure the accuracy and authority of the diagnostic results.

In terms of interdisciplinary collaboration and regional radiation, the department actively strengthened cooperation with clinical departments, and regularly conducted multi-disciplinary consultations (MDT) for complex and difficult cases to provide patients with integrated and personalized treatment plans. Additionally, the department actively fulfilled its regional medical responsibilities, undertaking the consultation work of pathological specimens for grassroots hospitals, and through technical guidance, academic exchanges, etc., helping to enhance the homogeneity of pathological diagnosis levels within the region. In the fields of teaching and research, the department steadily advanced the standardized training of resident physicians, undertook multiple provincial and municipal research projects, published numerous high-level academic papers, and achieved coordinated development in clinical, teaching, and research. This successful approval of the Chengdu Clinical Key Specialty is a new starting point and also a new responsibility. The Chengdu High-tech Medical Association Western Precision Medicine and Molecular Pathology Special Committee and the Fifth People's Hospital of Chengdu Pathology Department will take this as an opportunity to continuously deepen talent cultivation, technological innovation, and discipline construction, continuously improving the accuracy and service efficiency of pathological diagnosis, and making greater contributions to safeguarding the lives and health of the people and promoting the high-quality development of the medical and health industry.